AFJK: Aimei Health Technology Co Ltd Financial Statements

Balance sheet, income statement, and cash flow statements for Aimei Health Technology Co Ltd (AFJK).

OverviewDividends

$96.58M Market Cap.

As of 03/31/2025 5:00 PM ET (MRY) • Disclaimer

AFJK Market Cap. (MRY)


AFJK Shares Outstanding (MRY)


AFJK Assets (MRY)


Total Assets

$73.81M

Total Liabilities

$1.51M

Total Investments

$73.78M

AFJK Income (MRY)


Revenue

$0

Net Income

$2.55M

Operating Expense

$1.06M

AFJK Cash Flow (MRY)


CF Operations

-$672.29K

CF Investing

-$277.70K

CF Financing

$397.48K

AFJK Balance Sheet (MRY)


Metric

2024

Total Assets

$73,814,933

Assets Current

$30,384

Assets Non-Current

$73,784,549

Goodwill & Intangible Assets

$0

Shareholders Equity

-$1,476,610

Property Plant & Equipment Net

$0

Cash & Equivalents

$28,208

Accumulated Other Comprehensive Income

$0

Deferred Revenue

$0

Total Investments

$73,784,549

Investments Current

$0

Investments Non-Current

$73,784,549

Inventory

$0

Trade & Non-Trade Receivables

$0

Trade & Non-Trade Payables

$289,780

Accumulated Retained Earnings (Deficit)

-$1,476,823

Tax Assets

$0

Tax Liabilities

$0

Total Debt

$227,700

Debt Current

$227,700

Debt Non-Current

$0

Total Liabilities

$1,506,994

Liabilities Current

$816,994

Liabilities Non-Current

$690,000

AFJK Income Statement (MRY)


Metric

2024

Revenues

$0

Cost of Revenue

$0

Selling General & Administrative Expense

$1,064,786

Research & Development Expense

$0

Operating Expenses

$1,064,786

Interest Expense

$0

Income Tax Expense

$0

Net Loss Income from Discontinued Operations

$0

Consolidated Income

$2,552,215

Net Income to Non-Controlling Interests

$0

Net Income

$2,552,215

Preferred Dividends Income Statement Impact

$0

Net Income Common Stock

$2,552,215

Weighted Average Shares

$9,026,000

Weighted Average Shares Diluted

$9,026,000

Earning Before Interest & Taxes (EBIT)

$2,552,215

Gross Profit

$0

Operating Income

-$1,064,786

AFJK Cash Flow Statement (MRY)


Metric

2024

Net Cash Flow from Investing

-$277,700

Net Cash Flow from Financing

$397,480

Net Cash Flow from Operations

-$672,289

Net Cash Flow / Change in Cash & Cash Equivalents

-$552,509

Net Cash Flow - Business Acquisitions and Disposals

$0

Net Cash Flow - Investment Acquisitions and Disposals

-$277,700

Capital Expenditure

$0

Issuance (Repayment) of Debt Securities

$397,480

Issuance (Purchase) of Equity Shares

$0

Payment of Dividends & Other Cash Distributions

$0

Effect of Exchange Rate Changes on Cash

$0

Share Based Compensation

$0

Depreciation Amortization & Accretion

$0

AFJK Financial Metrics (MRY)


Metric

2024

Gross Margin

-

Profit Margin

-

EBITDA Margin

-

Return on Average Equity (ROAE)

-323.30%

Return on Average Assets (ROAA)

3.50%

Return on Sales (ROS)

-

Return on Invested Capital (ROIC)

3.50%

Dividend Yield

0%

Price to Earnings Ratio (P/E)

38.21

Price to Sales Ratio (P/S)

-

Price to Book Ratio (P/B)

-65.41

Debt to Equity Ratio (D/E)

-1.02

Earnings Per Share (EPS)

0.28

Sales Per Share (SPS)

0

Free Cash Flow Per Share (FCFPS)

-0.07

Book Value Per Share (BVPS)

-0.16

Tangible Assets Book Value Per Share (TABVPS)

8.18

Enterprise Value Over EBIT (EV/EBIT)

38

Enterprise Value Over EBITDA (EV/EBITDA)

37.8

Asset Turnover

0

Current Ratio

0.04

Dividends

$0

Free Cash Flow (FCF)

-$672,289

Enterprise Value (EV)

$96,474,641

Earnings Before Tax (EBT)

$2,552,215

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$2,552,215

Invested Capital

$73,197,431

Working Capital

-$786,610

Tangible Asset Value

$73,814,933

Market Capitalization

$96,578,200

Average Equity

-$789,531

Average Assets

$72,450,194

Invested Capital Average

$72,021,996

Shares

9,026,000